ConductScience.org, home

Paper1918136

Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.

Quax PH and 6 others. J Cell Biol, 1991. Cited by 158 papers, by iCite.

Cite this record

ConductScience Library. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. Papers, record 1918136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1918136

Download JSON
Cell line
M1456 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
PubMed
Journal
J Cell Biol
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
158
iCite
Relative citation ratio, by iCite
4.1
iCite
Revised in PubMed
2019-05-08
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Quax PHP H
2van Muijen GNG N
3Weening-Verhoeff EJE J
4Lund LRL R
5Danø KK
6Ruiter DJD J
7Verheijen JHJ H

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Extracellular MatrixMajor topic
MelanomaMajor topic
Neoplasm MetastasisMajor topic
Plasminogen InactivatorsMajor topic
Urokinase-Type Plasminogen ActivatorMajor topic
Animals
Blotting, Northern
Gene Expression
Humans
In Vitro Techniques
Mice
Mice, Nude
Neoplasm Transplantation
RNA, Messenger
Tissue Plasminogen Activator

Source PubMed

Download CSV of topics

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12156852The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.J Biol Chem1990https://conductscience.org/library/papers/2156852PubMed
22544876Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2544876PubMed
32105839Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.Cancer Res1990https://conductscience.org/library/papers/2105839PubMed
42157592Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.EMBO J1990https://conductscience.org/library/papers/2157592PubMed
52161846Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.J Biol Chem1990https://conductscience.org/library/papers/2161846PubMed
62503527Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.J Cell Biol1989https://conductscience.org/library/papers/2503527PubMed
72793248Metalloproteinases and cancer invasion and metastasis.Int J Cancer1989https://conductscience.org/library/papers/2793248PubMed
82536017Characterization of the cellular binding site for the urokinase-type plasminogen activator.J Biol Chem1989https://conductscience.org/library/papers/2536017PubMed
92521625Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes.J Biol Chem1989https://conductscience.org/library/papers/2521625PubMed
102848851In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase.J Cell Biol1988https://conductscience.org/library/papers/2848851PubMed
113031083Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.J Cell Biol1987https://conductscience.org/library/papers/3031083PubMed
123104349Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.J Cell Biol1987https://conductscience.org/library/papers/3104349PubMed
133031025The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.J Biol Chem1987https://conductscience.org/library/papers/3031025PubMed
143123496Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts.J Cell Biol1988https://conductscience.org/library/papers/3123496PubMed
152828365A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.J Biol Chem1988https://conductscience.org/library/papers/2828365PubMed
162823896Proteolytic degradation of extracellular matrix in tumor invasion.Biochim Biophys Acta1987https://conductscience.org/library/papers/2823896PubMed
172963689Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.Cancer Res1988https://conductscience.org/library/papers/2963689PubMed
183129438Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin.J Cell Biol1988https://conductscience.org/library/papers/3129438PubMed
193023400The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.J Cell Biol1986https://conductscience.org/library/papers/3023400PubMed
203023326Binding of single-chain prourokinase to the urokinase receptor of human U937 cells.J Biol Chem1986https://conductscience.org/library/papers/3023326PubMed

See all 61 referencesDownload CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 158 citations.

PMIDTitleJournalYearIn PapersSource
34837514Exosomes produced by melanoma cells significantly influence the biological properties of normal and cancer-associated fibroblasts.Histochem Cell Biol2022https://conductscience.org/library/papers/34837514PubMed
34077708Interpretable deep learning uncovers cellular properties in label-free live cell images that are predictive of highly metastatic melanoma.Cell Syst2021https://conductscience.org/library/papers/34077708PubMed
33225419Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo.Cancer Immunol Immunother2021https://conductscience.org/library/papers/33225419PubMed
29216889Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.J Exp Clin Cancer Res2017https://conductscience.org/library/papers/29216889PubMed
28213832Dynamic Fluorescence Microscopy of Cellular Uptake of Intercalating Model Drugs by Ultrasound-Activated Microbubbles.Mol Imaging Biol2017https://conductscience.org/library/papers/28213832PubMed
23039186LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro.BMC Cancer2012https://conductscience.org/library/papers/23039186PubMed
22716255SERPINE1 expression discriminates site-specific metastasis in human melanoma.Exp Dermatol2012https://conductscience.org/library/papers/22716255PubMed
22098560Reprogramming urokinase into an antibody-recruiting anticancer agent.ACS Chem Biol2012https://conductscience.org/library/papers/22098560PubMed
22098548Plasminogen activator inhibitor 1 RNAi suppresses gastric cancer metastasis in vivo.Cancer Sci2012https://conductscience.org/library/papers/22098548PubMed
21555554Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21555554PubMed
19623162Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved.Mol Ther2010https://conductscience.org/library/papers/19623162PubMed
15701164Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity.Cancer Cell Int2005https://conductscience.org/library/papers/15701164PubMed
11592301Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro.Clin Exp Metastasis2000https://conductscience.org/library/papers/11592301PubMed
11044361High tPA-expression in primary melanoma of the limb correlates with good prognosis.Br J Cancer2000https://conductscience.org/library/papers/11044361PubMed
10066093Urokinase induces receptor mediated brain tumor cell migration and invasion.J Neurooncol1998https://conductscience.org/library/papers/10066093PubMed
9303353Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential.Br J Cancer1997https://conductscience.org/library/papers/9303353PubMed
9202057Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.J Clin Invest1997https://conductscience.org/library/papers/9202057PubMed
8830783Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?J Cell Biol1996https://conductscience.org/library/papers/8830783PubMed
8818187Role of fibroblasts in the regulation of proinflammatory interleukin IL-1, IL-6 and IL-8 levels induced by keratinocyte-derived IL-1.Arch Dermatol Res1996https://conductscience.org/library/papers/8818187PubMed
8621764Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model.J Clin Invest1996https://conductscience.org/library/papers/8621764PubMed

See all 29 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PLAT5327PubTator's text mininghttps://conductscience.org/library/genes/5327NCBI Gene
PLAU5328PubTator's text mininghttps://conductscience.org/library/genes/5328NCBI Gene
PLAUR5329PubTator's text mininghttps://conductscience.org/library/genes/5329NCBI Gene
PLG5340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
SERPINB25055PubTator's text mininghttps://conductscience.org/library/genes/5055NCBI Gene
SERPINE15054PubTator's text mininghttps://conductscience.org/library/genes/5054NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1918136

GET https://conductscience.org/api/papers/v1/1918136/references?page=2